Important Safety Information for Ozempic WARNING: RISK OF THYROID C-CELL TUMORS In rodents, semaglutide causes dose-dependent and treatment-duration- dependent thyroid C-cell tumors at clinically relevant exposures
August 2, 2024: Blood Clots, DVT, Pulmonary Embolisms Possibly Linked to GLP-1 Drugs A data analysis published in the Endocrine Journal has medical professionals taking a new look at how semaglutide drugs might cause a specific type of blood clot
The intersection of nutrition and peptide therapy is one of the most important but least discussed aspects of getting optimal results from any GLP-1 medication
Clinical trials demonstrate 15 to 20 percent total body weight loss over 72 weeks
Are you measuring portions or estimating
From the very first interaction, the team was professional, knowledgeable, and supportive